TERN
Terns Pharmaceuticals, Inc.
Insiders sold $1.3M net in the last 90 days ·2 sellers, 0 buyers· 2 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Apr 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.1M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
May 5, 2026
Kuriakose Emil
Terns Pharmaceuticals, Inc. (TERN) has 13 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 5, 2026.
Inside the rolling window, 3 insiders at Terns Pharmaceuticals, Inc. reported no open-market purchases and 8 open-market sales totaling $7.1M. The most active filer is Chief Executive Officer Burroughs Amy L. with 4 filings. Insiders have net sold $6.6M over the trailing 6 months. The most recent open-market filing is a sale of 942 shares by Chief Medical Officer Kuriakose Emil, dated Apr 1, 2026, worth $50K.
- Industry:Biotechnology
- CEO:Amy L. Burroughs
- Employees:59
- HQ:Foster City, CA, US
- IPO:2021-02-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 942 | $50K | Apr 2 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 14,583 | $681K | Mar 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 14,583 | $572K | Feb 18 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 68,749 | $2.5M | Jan 16 | — | SEC ↗ | |
Burroughs Amy L.First filing | Chief Executive Officer | Sale | 71,339 | $2.7M | Jan 6 | — | SEC ↗ |
Kuriakose EmilFirst in 3 months | Chief Medical Officer | Sale | 1,155 | $45K | Jan 6 | — | SEC ↗ |
Quigley Jill M.First filing | Director | Sale | 24,520 | $441K | Nov 5 | — | SEC ↗ |
Kuriakose EmilFirst filing | Chief Medical Officer | Sale | 944 | $7K | Oct 2 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TERN have?
Terns Pharmaceuticals, Inc. (TERN) has 13 SEC Form 4 filings (27 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: May 5, 2026.
When was the most recent SEC Form 4 filing for TERN?
The most recent Form 4 filing for TERN on Tracefour is dated May 5, 2026.
Who is the most active insider at TERN?
The most active SEC Form 4 filer at TERN in the rolling window is Chief Executive Officer Burroughs Amy L., with 4 filings.
What is the net insider flow at TERN over the last 6 months?
Over the trailing 180 days, insiders at TERN have net sold $6.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TERN in the current window?
Inside the rolling window, insiders at TERN bought $0 and sold $7.1M based on SEC Form 4 filings.
Can I get alerts for TERN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Terns Pharmaceuticals, Inc. (TERN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.